Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001376013.1(EPB41):c.238T>C(p.Ser80Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,461,886 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
EPB41 (HGNC:3377): (erythrocyte membrane protein band 4.1) The protein encoded by this gene, together with spectrin and actin, constitute the red cell membrane cytoskeletal network. This complex plays a critical role in erythrocyte shape and deformability. Mutations in this gene are associated with type 1 elliptocytosis (EL1). Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Oct 2009]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The EPB41 gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_001166005.1, and corresponds to NM_004437.3:c.-470T>C in the primary transcript. This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 80 of the EPB41 protein (p.Ser80Pro). This variant is present in population databases (no rsID available, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with EPB41-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);Loss of phosphorylation at S80 (P = 0.0011);